Abattis Bioceuticals (Abattis Bioceuticals) Interest Expense : $-0.04 Mil (TTM As of Sep. 2019)

View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Abattis Bioceuticals's interest expense for the three months ended in Sep. 2019 was $ -0.03 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2019 was $-0.04 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Abattis Bioceuticals's Operating Income for the three months ended in Sep. 2019 was $ -0.39 Mil. Abattis Bioceuticals's Interest Expense for the three months ended in Sep. 2019 was $ -0.03 Mil. Abattis Bioceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Abattis Bioceuticals Interest Expense Historical Data

The historical data trend for Abattis Bioceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Interest Expense Chart

Abattis Bioceuticals Annual Data

Trend

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Interest Expense

Get a 7-Day Free Trial

-0.03

-0.02

-0.01

-3.33

-0.04

Abattis Bioceuticals Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Interest Expense	Get a 7-Day Free Trial															-3.32	-	-	-	-0.03

Abattis Bioceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04 Mil.

Abattis Bioceuticals (OTCPK:ATTBF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Abattis Bioceuticals's Interest Expense for the three months ended in Sep. 2019 was $-0.03 Mil. Its Operating Income for the three months ended in Sep. 2019 was $-0.39 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2019 was $0.09 Mil.

Abattis Bioceuticals's Interest Coverage for the quarter that ended in Sep. 2019 is calculated as

Abattis Bioceuticals did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6

Website

http://www.abattis.com

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.